Total Payments
$11,794
2024 Payments
$1,256
Companies
46
Transactions
720
Medicare Patients
5,361
Medicare Billing
$557,642
Payment Breakdown by Category
Food & Beverage$11,308 (95.9%)
Travel$482.00 (4.1%)
Education$4.20 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,308 | 717 | 95.9% |
| Travel and Lodging | $482.00 | 2 | 4.1% |
| Education | $4.20 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,734 | 232 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,727 | 114 | $0 (2024) |
| Covidien LP | $605.13 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $514.14 | 39 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $477.20 | 30 | $0 (2023) |
| PFIZER INC. | $456.37 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $360.96 | 31 | $0 (2024) |
| Allergan Inc. | $331.82 | 36 | $0 (2019) |
| NESTLE HEALTHCARE NUTRITION INC. | $314.43 | 17 | $0 (2023) |
| Gilead Sciences, Inc. | $301.68 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,256 | 65 | ABBVIE INC. ($634.63) |
| 2023 | $1,926 | 124 | ABBVIE INC. ($559.17) |
| 2022 | $2,215 | 127 | ABBVIE INC. ($807.35) |
| 2021 | $522.36 | 24 | AbbVie Inc. ($299.33) |
| 2020 | $346.31 | 25 | AbbVie Inc. ($120.85) |
| 2019 | $1,729 | 125 | AbbVie, Inc. ($398.48) |
| 2018 | $2,343 | 125 | AbbVie, Inc. ($627.35) |
| 2017 | $1,456 | 105 | AbbVie, Inc. ($287.21) |
All Payment Transactions
720 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Micro-tech Endoscopy USA, Inc. | LesionHunter (Device) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: GI Endoscopy | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: VIROLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/30/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
| 06/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,291 | 1,379 | $738,796 | $141,389 |
| 2022 | 16 | 1,313 | 1,374 | $693,095 | $136,224 |
| 2021 | 20 | 1,384 | 1,466 | $726,380 | $146,990 |
| 2020 | 18 | 1,373 | 1,458 | $665,295 | $133,038 |
Total Patients
5,361
Total Services
5,677
Medicare Billing
$557,642
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 109 | 109 | $131,345 | $21,077 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 216 | $53,630 | $18,186 | 33.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 131 | 131 | $128,380 | $17,020 | 13.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 83 | 83 | $70,550 | $14,034 | 19.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $36,980 | $12,555 | 33.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 73 | 73 | $62,050 | $12,513 | 20.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 52 | $18,200 | $6,778 | 37.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 96 | 99 | $68,805 | $6,486 | 9.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 80 | 81 | $46,575 | $5,765 | 12.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 95 | $17,176 | $5,553 | 32.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $34,000 | $5,312 | 15.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 38 | 39 | $33,150 | $3,999 | 12.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 56 | $7,560 | $3,251 | 43.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 47 | 59 | $6,100 | $2,219 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $7,245 | $2,121 | 29.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 30 | $3,600 | $1,351 | 37.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 38 | $3,420 | $1,334 | 39.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,530 | $1,087 | 43.0% |
| 43450 | Dilation of esophagus | Facility | 2023 | 25 | 25 | $7,500 | $747.95 | 10.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 115 | 115 | $138,575 | $21,532 | 15.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 121 | 121 | $118,580 | $14,690 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $34,060 | $13,950 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 154 | $26,180 | $13,340 | 51.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 72 | 72 | $61,200 | $12,521 | 20.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 76 | 76 | $26,600 | $11,301 | 42.5% |
About Dr. Eric Ormseth, M.D
Dr. Eric Ormseth, M.D is a Gastroenterology healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982686515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Ormseth, M.D has received a total of $11,794 in payments from pharmaceutical and medical device companies, with $1,256 received in 2024. These payments were reported across 720 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,308).
As a Medicare-enrolled provider, Ormseth has provided services to 5,361 Medicare beneficiaries, totaling 5,677 services with total Medicare billing of $557,642. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Southaven, MS
- Active Since 11/18/2005
- Last Updated 03/05/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1982686515
Products in Payments
- XIFAXAN (Drug) $1,046
- RINVOQ (Biological) $1,040
- Humira (Biological) $632.15
- LINZESS (Drug) $449.13
- HUMIRA (Biological) $414.21
- Mavyret (Drug) $411.94
- XELJANZ (Drug) $408.75
- TRULANCE (Drug) $399.75
- Barrx (Device) $326.78
- STELARA (Biological) $294.76
- DUPIXENT (Biological) $290.73
- CLENPIQ (Drug) $286.81
- ZENPEP (Drug) $282.54
- SKYRIZI (Biological) $266.98
- ZEPOSIA (Drug) $249.76
- OCALIVA (Drug) $233.31
- MAVYRET (Drug) $229.93
- ENTYVIO (Biological) $217.08
- LINX Reflux Management System (Device) $216.02
- Creon (Drug) $182.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Southaven
Dr. Nabeel Khan, M.d, M.D
Gastroenterology — Payments: $25,632
Gastroenterology $25,632
Dr. Geza Remak, M.d, M.D
Gastroenterology — Payments: $10,322
Gastroenterology $10,322
Dr. Christopher Griffith, M.d, M.D
Gastroenterology — Payments: $7,776
Gastroenterology $7,776
Sufiyan Chaudhry, Md, MD
Gastroenterology — Payments: $4,971
Gastroenterology $4,971